Logo image of BCO.DE

BOEING CO/THE (BCO.DE) Stock Fundamental Analysis

FRA:BCO - Deutsche Boerse Ag - US0970231058 - Common Stock - Currency: EUR

183.42  +5.36 (+3.01%)

Fundamental Rating

1

Overall BCO gets a fundamental rating of 1 out of 10. We evaluated BCO against 43 industry peers in the Aerospace & Defense industry. BCO may be in some trouble as it scores bad on both profitability and health. BCO does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

BCO had negative earnings in the past year.
In the past year BCO has reported a negative cash flow from operations.
BCO had negative earnings in each of the past 5 years.
In multiple years BCO reported negative operating cash flow during the last 5 years.
BCO.DE Yearly Net Income VS EBIT VS OCF VS FCFBCO.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B

1.2 Ratios

Looking at the Return On Assets, with a value of -7.45%, BCO is doing worse than 86.05% of the companies in the same industry.
Industry RankSector Rank
ROA -7.45%
ROE N/A
ROIC N/A
ROA(3y)-4.27%
ROA(5y)-4.73%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BCO.DE Yearly ROA, ROE, ROICBCO.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K

1.3 Margins

BCO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BCO.DE Yearly Profit, Operating, Gross MarginsBCO.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

More info and screens

1

2. Health

2.1 Basic Checks

BCO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BCO has more shares outstanding
BCO has more shares outstanding than it did 5 years ago.
The debt/assets ratio for BCO has been reduced compared to a year ago.
BCO.DE Yearly Shares OutstandingBCO.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BCO.DE Yearly Total Debt VS Total AssetsBCO.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

Based on the Altman-Z score of 1.12, we must say that BCO is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.12, BCO is doing worse than 81.40% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.12
ROIC/WACCN/A
WACC9.42%
BCO.DE Yearly LT Debt VS Equity VS FCFBCO.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B

2.3 Liquidity

A Current Ratio of 1.23 indicates that BCO should not have too much problems paying its short term obligations.
The Current ratio of BCO (1.23) is comparable to the rest of the industry.
BCO has a Quick Ratio of 1.23. This is a bad value and indicates that BCO is not financially healthy enough and could expect problems in meeting its short term obligations.
BCO has a Quick ratio of 0.37. This is amonst the worse of the industry: BCO underperforms 95.35% of its industry peers.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 0.37
BCO.DE Yearly Current Assets VS Current LiabilitesBCO.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for BCO have decreased strongly by -247.36% in the last year.
Looking at the last year, BCO shows a decrease in Revenue. The Revenue has decreased by -9.15% in the last year.
BCO shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.74% yearly.
EPS 1Y (TTM)-247.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.64%
Revenue 1Y (TTM)-9.15%
Revenue growth 3Y2.21%
Revenue growth 5Y-4.74%
Sales Q2Q%17.67%

3.2 Future

The Earnings Per Share is expected to grow by 18.96% on average over the next years. This is quite good.
The Revenue is expected to grow by 13.88% on average over the next years. This is quite good.
EPS Next Y91.71%
EPS Next 2Y47.77%
EPS Next 3Y32.65%
EPS Next 5Y18.96%
Revenue Next Year23.81%
Revenue Next 2Y20.52%
Revenue Next 3Y17.14%
Revenue Next 5Y13.88%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BCO.DE Yearly Revenue VS EstimatesBCO.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50B 100B 150B
BCO.DE Yearly EPS VS EstimatesBCO.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 10 -10 -20

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

BCO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 55.49, BCO can be considered very expensive at the moment.
83.72% of the companies in the same industry are cheaper than BCO, based on the Price/Forward Earnings ratio.
BCO is valuated expensively when we compare the Price/Forward Earnings ratio to 22.13, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 55.49
BCO.DE Price Earnings VS Forward Price EarningsBCO.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BCO.DE Per share dataBCO.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

BCO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BCO's earnings are expected to grow with 32.65% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.77%
EPS Next 3Y32.65%

More info and screens

0

5. Dividend

5.1 Amount

BCO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BOEING CO/THE

FRA:BCO (5/29/2025, 5:20:07 PM)

183.42

+5.36 (+3.01%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)04-23 2025-04-23/bmo
Earnings (Next)07-29 2025-07-29/bmo
Inst Owners75.41%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap138.30B
Analysts78.92
Price Target178.19 (-2.85%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-13.94%
Min EPS beat(2)-91.07%
Max EPS beat(2)63.2%
EPS beat(4)2
Avg EPS beat(4)-16.75%
Min EPS beat(4)-91.07%
Max EPS beat(4)63.2%
EPS beat(8)5
Avg EPS beat(8)2.53%
EPS beat(12)5
Avg EPS beat(12)-793.15%
EPS beat(16)6
Avg EPS beat(16)-758.16%
Revenue beat(2)0
Avg Revenue beat(2)-5.7%
Min Revenue beat(2)-8.71%
Max Revenue beat(2)-2.69%
Revenue beat(4)0
Avg Revenue beat(4)-4.79%
Min Revenue beat(4)-8.71%
Max Revenue beat(4)-2.69%
Revenue beat(8)2
Avg Revenue beat(8)-2.15%
Revenue beat(12)2
Avg Revenue beat(12)-3.63%
Revenue beat(16)2
Avg Revenue beat(16)-5.09%
PT rev (1m)-5.96%
PT rev (3m)-1.74%
EPS NQ rev (1m)-39.86%
EPS NQ rev (3m)-37.04%
EPS NY rev (1m)9.99%
EPS NY rev (3m)-8.5%
Revenue NQ rev (1m)-2.33%
Revenue NQ rev (3m)-1.79%
Revenue NY rev (1m)-1.16%
Revenue NY rev (3m)-0.77%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 55.49
P/S 2.25
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-17.43
EYN/A
EPS(NY)3.31
Fwd EY1.8%
FCF(TTM)-14.95
FCFYN/A
OCF(TTM)-12.11
OCFYN/A
SpS81.38
BVpS-3.9
TBVpS-15.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.45%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.27%
ROA(5y)-4.73%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 130.38%
Cap/Sales 3.49%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 0.37
Altman-Z 1.12
F-Score3
WACC9.42%
ROIC/WACCN/A
Cap/Depr(3y)90.02%
Cap/Depr(5y)74.76%
Cap/Sales(3y)2.43%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-247.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.64%
EPS Next Y91.71%
EPS Next 2Y47.77%
EPS Next 3Y32.65%
EPS Next 5Y18.96%
Revenue 1Y (TTM)-9.15%
Revenue growth 3Y2.21%
Revenue growth 5Y-4.74%
Sales Q2Q%17.67%
Revenue Next Year23.81%
Revenue Next 2Y20.52%
Revenue Next 3Y17.14%
Revenue Next 5Y13.88%
EBIT growth 1Y-1098.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year149.79%
EBIT Next 3Y49.92%
EBIT Next 5Y32.37%
FCF growth 1Y-351.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-261.22%
OCF growth 3YN/A
OCF growth 5YN/A